All-site cancer incidence

How it is measured

Proportion of participants with a newly diagnosed cancer of any site, all sites combined, over the follow-up the source states, ascertained by cancer registry linkage, pathology report, adjudicated clinical report or medical record review. Whether non-melanoma skin cancer is counted is recorded with each finding.